MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Application and correlates of the PSP quality of life scale

L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

Meeting: 2016 International Congress

Abstract Number: 208

Keywords: Gait disorders: Clinical features, Parkinsonism, Progressive supranuclear palsy(PSP), Scales

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating scale (PSPRS).

Background: Despite the widespread recognition of PSP as a distinct disease entity with a well-defined set of disabling symptoms, there have been very few published scales dedicated specifically to the assessment of this disease. The PSP rating scale (PSPRS) has emerged as a useful and broadly validated measurement of disease severity. However, there is no widely used disease-specific QoL scale. The PSP-QoL, a 45-item questionnaire developed by Schrag et al (Neurology 2006;67:39-44), is the only published PSP-specific QoL assessment tool, but has been formally assessed only within a single referral center. Furthermore, its interscale correlations with the PSPRS have not been explored. The utilization of the PSP-QoL within additional PSP populations and examination of its PSPRS correlates would help firmly establish the PSP-QoL as a reliable tool and provide insight regarding determinants of QoL in PSP patients.

Methods: Descriptive statistics included means and standard deviations. Partial correlation analysis adjusted for age and disease duration was used to cross-sectionally evaluate the relationship between total and subscale PSP-QoL scores and total and subscale PSPRS scores, respectively.

Results: Among 15 PSP patients (8M:7W; 13 Caucasian, 2 African-American) seen in our multidisciplinary research clinic (mean(sd) age=73.4(7.1)); disease duration=3.4(2.2) years), there was a significant positive correlation between total PSP-QoL and PSPRS scores (r=0.639, p=0.019) obtained within 1 week of each other. The mentation and physical subscales of each instrument also demonstrated significant positive interscale correlations (r=0.661, p=0.014; r=0.631, p=0.021). Of the subscale components of the PSPRS, gait impairment strongly correlated with overall physical impairment on the PSP-QoL (r=0.761, p=0.003), while mental impairment demonstrated the strongest negative correlation with PSP-QoL overall life satisfaction scores (r= -0.596, p=0.031).

Conclusions: Our results demonstrate significant interscale correlations between the total and subscale scores of the PSP-QoL and PSPRS, supporting the validity of the PSP-QoL and its application in multiple PSP populations. Longitudinal analyses among larger patient samples are required to affirm the utility of the scale.

To cite this abstract in AMA style:

L.A. Higginbotham, V. Johnson, A. Pantelyat. Application and correlates of the PSP quality of life scale [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/application-and-correlates-of-the-psp-quality-of-life-scale/. Accessed July 3, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/application-and-correlates-of-the-psp-quality-of-life-scale/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley